Target intelligence / Profile preview

MicroRNA 644a (MIR644A)

Target
MIR644A
Molecular classification
microRNA, non-coding RNA
01

Overview

MicroRNA 644a (MIR644A) is a short, endogenous non-coding RNA that regulates gene expression by binding to complementary sequences in the 3’-untranslated region (3’-UTR) of target mRNAs, leading to mRNA degradation or translational inhibition[2]. MIR644A is transcribed by RNA polymerase II as part of longer primary transcripts and processed sequentially by Drosha and Dicer enzymes to produce a mature miRNA, which is integrated into the RNA-induced silencing complex (RISC) to exert its function[2]. In hepatocellular carcinoma cells, miR-644a is downregulated compared to normal tissue, and restoration of its expression induces apoptosis by directly inhibiting Heat Shock Factor 1 (HSF1), a key transcription factor involved in stress response and cell survival[1]. Overexpression of miR-644a increases levels of pro-apoptotic BH3-only proteins (such as BID, BAD, BIM, SMAC, Apaf-1), further supporting its role in promoting cell death. miR-644a has also been described as a tumor suppressor in other cancers, including breast and esophageal cancer, where it modulates proliferation and drug resistance[1]. Overall, miR-644a is considered a potential prognostic biomarker and an experimental therapeutic target in oncology, though no approved drugs target it directly at present[1].

Other names
miR-644aMIR644MIRN644hsa-mir-644hsa-mir-644amicroRNA 644
02

Biological functions

Post-transcriptional gene regulationmRNA destabilizationTranslational inhibitionCell proliferation inhibitionPromotion of apoptosis
03

Disease associations

Cancer (Hepatocellular carcinoma, Breast cancer, Esophageal cancer)ChemoresistanceTumor suppression
04

Safety considerations

Potential off-target effects of miRNA mimics/inhibitorsrisk of broad gene regulatory impact due to many possible mRNA targets
05

Biomarkers

Prognostic biomarker for cancer progression and outcome, notably in hepatocellular carcinoma

Beyond the preview

Go deeper on MicroRNA 644a (MIR644A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 644a (MIR644A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call